Brief IA
›

Isomorphic Labs Raises $5 Billion in Series C Funding

Business & Startups·Tom Levy·

Isomorphic Labs Raises $5 Billion in Series C Funding

Isomorphic Labs Raises $5 Billion in Series C Funding
Key Takeaways
1Isomorphic Labs raised $5 billion in Series C.
2Science tops the weekly ranking with $400 million in Series D.
3Model ML closes a $250 million Series B, with a valuation of $1.5 billion.
Why it matters : These funding rounds support companies applying AI to drug discovery and financial and professional services.

Isomorphic Labs, a London-based company applying AI to drug discovery, has secured $5 billion in a Series C funding round. In the separate weekly ranking of this international operation, Science takes the lead with $400 million, followed by Model ML.

Science and Model ML at the Top of the Ranking

Based in Alameda, California, Science focuses on brain-computer interfaces and neural engineering. Its Series D funding brings the total capital raised since its inception to over $900 million. Model ML, which offers an AI platform for financial and professional services, has completed a Series B round of $250 million, led by General Atlantic and QED Investors. Present in both New York and London, this three-year-old company reaches a valuation of $1.5 billion.

In Redwood City, California, Galvanize Therapeutics has raised $130 million in a Series D round, with HealthQuest Capital leading the operation. Its pulsed electric field ablation technologies target oncology and chronic diseases.

General Flash, on the other hand, announces $128 million raised from various investors during seed and Series A rounds. The company is developing a new process for producing critical metals. Next is Ramon.Space, a specialist in space computing infrastructure based in Denver. Its Series B round reaches $124 million, led by PSG.

La lettre du soirGratuit · 19 h

Le brief IA que les pros lisent chaque soir

Les 7 actus IA du jour, décryptées en 5 min. Gratuit.

Inclus dès l'inscription : notre sélection des meilleurs guides & comparatifs IA.

Choisissez votre rythme

Gratuit · Pas de spam · Désabonnement en 1 clic

From Marrow Therapeutics to Vincue

Marrow Therapeutics announces its launch with $173 million raised in Series A and B rounds. The second round, led by Orbimed, amounts to $120 million; the first, led by Scion Life Sciences with venBio, reaches $53 million. Based in Watertown, Massachusetts, the company is developing treatments targeting the bone marrow for severe blood disorders.

Noeri starts with $110 million raised in an initial funding round led by Menlo Ventures. Founded by computer science professors from Stanford University and located in Palo Alto, it is developing self-improving AI for both businesses and researchers. In San Diego, Seawolf Therapeutics emerges from its discretion phase and announces a cumulative funding of $100 million. This biotechnology company is preparing a new DNA delivery platform, with major investors including Versant Ventures, MPM BioImpact, and Novartis Venture Fund.

BrightAI secures an additional $97 million in a round led by Smith Point Capital. Based in Silicon Valley, it is developing a platform that combines sensors, drones, and robotics to continuously monitor sectors with significant infrastructure, particularly energy. Finally, Vincue raises $93 million in growth capital, led by Wavecrest Growth Partners. The Kansas City-based company is developing a vehicle lifecycle intelligence platform.

Greenoaks and Sequoia Fund Isomorphic Labs

Greenoaks and Sequoia Capital led the funding for Isomorphic Labs. The company has been in existence for five years and, in addition to its London location, has offices in Massachusetts and Switzerland.

Brief IA — L'actualité IA en français

L'essentiel de l'actualité de l'intelligence artificielle, décrypté et expliqué chaque jour.